Skip to main content

Table 3 Baseline characteristics of PSM cohort

From: The impact of type 2 diabetes mellitus on the clinical profile, myocardial fibrosis, and prognosis in non-ischemic dilated cardiomyopathy: a prospective cohort study

 

With T2DM

No T2DM

P value

(n = 149)

(n = 289)

 

Male, n

111 (75%)

219 (76%)

0.77

Age (years)

54 ± 12

54 ± 13

0.64

BMI (kg/m2)

24.5 ± 3.6

24.4 ± 4.1

0.92

SBP (mmHg)

116 ± 19

116 ± 17

0.99

DBP (mmHg)

76 ± 14

77 ± 13

0.53

NYHA class, n

  

0.24

 I

7 (5%)

21 (7%)

 

 II

53 (36%)

101 (35%)

 

 III

70 (47%)

114 (39%)

 

 IV

19 (13%)

53 (18%)

 

Hypertension, n

53 (36%)

100 (35%)

0.84

Atrial fibrillation, n

43 (29%)

75 (26%)

0.52

LBBB, n

17 (11%)

35 (12%)

0.83

Smoking, n

73 (49%)

136 (47%)

0.70

Alcohol, n

47 (32%)

100 (35%)

0.52

ACEI/ARB/ARNI, n

127 (85%)

247 (86%)

0.95

β-blockers, n

126 (85%)

244 (84%)

0.97

MRA, n

116 (78%)

221 (77%)

0.75

Diuretics, n

112 (75%)

213 (74%)

0.74

Digoxin, n

40 (27%)

69 (24%)

0.50

LVEDV index (ml/m2)

176 ± 64

177 ± 58

0.89

LVESV index (ml/m2)

139 ± 60

138 ± 56

0.79

LVM index (g/m2)

88 ± 28

86 ± 27

0.58

LVEF (%)

24 ± 10

24 ± 10

0.85

RVEDV index (ml/m2)

97 ± 37

96 ± 34

0.85

RVESV index (ml/m2)

66 ± 36

64 ± 34

0.61

RVEF (%)

36 ± 14

36 ± 14

0.64

LGE presence, n

82 (55%)

163 (56%)

0.79

Native T1 (ms)

1318 ± 81

1310 ± 73

0.24

ECV (%)

32.9 ± 6.4

32.6 ± 6.2

0.67

  1. Abbreviations: PSM, propensity score matching; other abbreviations as in Tables 1 and 2
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840